Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Hangzhou, Hutchmed, Reece, Sciwind.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Asieris, Aslan, Astellas, Astrazeneca, Biocity, Caliway, Canbridge, Daiichi Sankyo, Haemalogix, Horizon, Invivyd, Jacobio, Junshi, Microba, Nanoviricides, Neuren, Photocure, Sanofi, SK, Sorrento, Sosei, Takeda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aslan, Biocity, Curocell, Horizon, Invivyd, Minghui, Sumitomo, Takeda, Telix.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bavarian Nordic, Innocare, Mindrank AI, Olix, Takeda, Tessa.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astellas, Beigene, Harbour, Lianbio, Ractigen, Vivavision.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Alterity, Aum, Beijing Luzhu, Biophytis, Brii, Caliway, Canbridge, Connect, Harbour, Revive, Structure.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Acepodia, Allgenesis, Clarity, Daiichi Sankyo, Geovax, Hanall, Immunos, Immutep, Lynk, Minghui, Mink, Stemcyte.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Carsgen, Delta-Fly, Everest, Genome, Hefei Tianhui, Immutep, Lynk, Oramed, Transcenta.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Enanta, Innovent, Kintor, Novavax, Onocross, Qilu.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Boan, D&D, Eirgenix, Golden, Hyundai, Revive, Transcenta.